Home › Funds › Invesco Ltd › MDGL
Invesco Ltd position in MDGL
MADRIGAL PHARMACEUTICALS INC · Health Care
Latest position (Q2 2026)301.44K sh
Reported value held$161.86M
Portfolio Weight0.01%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 7.65K | $610.00K | New |
| Q4 2021 | 7.08K | $600.00K | Reduce |
| Q1 2022 | 5.27K | $518.00K | Reduce |
| Q2 2022 | 5.33K | $382.00K | Add |
| Q3 2022 | 5.97K | $388.00K | Add |
| Q4 2022 | 32.98K | $9.57M | Add |
| Q1 2023 | 22.09K | $5.35M | Reduce |
| Q2 2023 | 22.72K | $5.25M | Add |
| Q3 2023 | 7.11K | $1.04M | Reduce |
| Q4 2023 | 8.66K | $2.00M | Add |
| Q1 2024 | 80.19K | $21.41M | Add |
| Q2 2024 | 133.76K | $37.47M | Add |
| Q3 2024 | 120.25K | $25.52M | Reduce |
| Q4 2024 | 129.07K | $39.83M | Add |
| Q1 2025 | 132.93K | $44.03M | Add |
| Q2 2025 | 200.36K | $60.64M | Add |
| Q3 2025 | 299.56K | $137.40M | Add |
| Q4 2025 | 365.31K | $212.74M | Add |
| Q1 2026 | 329.52K | $172.49M | Reduce |
| Q2 2026 | 301.44K | $161.86M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding MDGL
- Vanguard Group 1.81M sh · $1.05B · Q4 2025
- Janus Henderson Group 2.02M sh · $1.05B · Q1 2026
- Paulson & Co 1.34M sh · $719.52M · Q2 2026
- BlackRock Inc 1.20M sh · $644.75M · Q2 2026
- Wellington Management Group 825.71K sh · $443.37M · Q2 2026
- Citadel Advisors 688.13K sh · $369.49M · Q2 2026
- UBS Group AG 401.71K sh · $215.70M · Q2 2026
- Geode Capital Management 374.88K sh · $201.34M · Q2 2026
- Fidelity Management & Research (FMR) 356.20K sh · $191.26M · Q2 2026
- Goldman Sachs Group 246.28K sh · $132.24M · Q2 2026
- Norges Bank Investment Management 213.89K sh · $114.85M · Q2 2026